BioRestorative Therapies, Inc.

BRTX · Nasdaq · SIC 8090: Services-Misc Health & Allied Services, NEC
272
SEC Filings

Business Summary

BioRestorative Therapies, Inc. (BRTX) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Its lead product, BRTX-100, is an autologous mesenchymal stem cell therapy in Phase 2 clinical trials for chronic lower back pain from degenerative disc disease. It also runs the ThermoStem Program for metabolic disorders using brown adipose stem cells, and operates a commercial biocosmeceutical platform producing a cell-based secretome serum.

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBRTXdiscussed_in_filing Cybersecurity
topic_mentionBRTXdiscussed_in_filing Trusted Computing
topic_mentionBRTXdiscussed_in_filing Blockchain & Crypto
topic_mentionBRTXdiscussed_in_filing Regulation
topic_mentionBRTXdiscussed_in_filing Healthcare & Bio
topic_mentionBRTXdiscussed_in_filing AI Compute
topic_mentionBRTXdiscussed_in_filing Platform & Ecosystem
topic_mentionBRTXdiscussed_in_filing Sovereign & Government
topic_mentionBRTXdiscussed_in_filing Cybersecurity
topic_mentionBRTXdiscussed_in_filing Trusted Computing
topic_mentionBRTXdiscussed_in_filing Blockchain & Crypto
topic_mentionBRTXdiscussed_in_filing Regulation
topic_mentionBRTXdiscussed_in_filing Healthcare & Bio
topic_mentionBRTXdiscussed_in_filing AI Compute
topic_mentionBRTXdiscussed_in_filing Platform & Ecosystem
topic_mentionBRTXdiscussed_in_filing Sovereign & Government
topic_mentionBRTXdiscussed_in_filing Cybersecurity
topic_mentionBRTXdiscussed_in_filing Trusted Computing
topic_mentionBRTXdiscussed_in_filing Blockchain & Crypto
topic_mentionBRTXdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001493152-26-012925EDGAR71K words
2025-03-282024-12-310001641172-25-001011EDGAR
2024-04-012023-12-310001493152-24-012056EDGAR
2023-03-272022-12-310001493152-23-008960EDGAR
2022-03-302021-12-310001493152-22-008184EDGAR
2021-04-302020-12-310001493152-21-010062EDGAR
2021-03-182019-12-310001493152-21-006285EDGAR
2019-03-292018-12-310001493152-19-004292EDGAR
2018-04-022017-12-310001493152-18-004554EDGAR
2017-03-222016-12-310001493152-17-002701EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001493152-25-021993EDGAR18K words
2025-08-122025-06-300001641172-25-023211EDGAR
2025-05-142025-03-310001641172-25-010299EDGAR
2024-11-122024-09-300001493152-24-044763EDGAR
2024-08-132024-06-300001493152-24-031636EDGAR
2024-06-112024-03-310001493152-24-023481EDGAR
2023-11-132023-09-300001493152-23-040483EDGAR
2023-08-112023-06-300001493152-23-027825EDGAR
2023-05-122023-03-310001493152-23-016630EDGAR
2022-11-142022-09-300001493152-22-031668EDGAR
2022-08-152022-06-300001493152-22-022617EDGAR
2022-05-162022-03-310001493152-22-013396EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-170001493152-26-006837EDGAR5K words
2025-11-120001021771-25-000148EDGAR
2025-10-080001493152-25-017446EDGAR
2025-09-250001021771-25-000131EDGAR
2025-08-140001021771-25-000116EDGAR
2025-08-120001021771-25-000113EDGAR
2025-06-130001021771-25-000092EDGAR
2025-05-140001021771-25-000079EDGAR
2025-04-210001021771-25-000074EDGAR
2025-03-270001021771-25-000066EDGAR

272 total filings indexed. 240 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

IMTH — AnTix Holdings, Inc. CCEL — CRYO CELL INTERNATIONAL INC DVA — DAVITA INC. MGRX — MANGOCEUTICALS, INC. MRAI — Marpai, Inc. OAKU — Oak Woods Acquisition Corp PFHO — PACIFIC HEALTH CARE ORGANIZATION INC PARK — Park Dental Partners, Inc.

Tags

disc-and-spine-disease-treatment metabolic-disorders-and-obesity biocosmeceuticals cell-and-gene-therapy cgmp-iso-7-certified-clean-room

Company Identity

CIK0001505497
TickerBRTX
ExchangeNasdaq
SIC8090: Services-Misc Health & Allied Services, NEC
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e19539628788a65df32c1d768522b864e71441bce39a8912e6d0fe0a4f328813
parent: 98258a20985c2094d0128d1ed3ab1fb8266a40c467ac49886e533051c97538e4
content hash: 250b2110278a2d7c3e4f43dd5f4b73842ed2aed87160acaedc7d69855a3c87f8
signed: 2026-04-13T04:44:05.850Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf